Canada bans some Dr. Reddy's products; Report suggests incentives to fight shortages; Gulf Pharma buys Bangladesh drugmaker;

> Health Canada has stopped allowing imports from a Dr. Reddy's Laboratories plant in Srikakulam that was cited by the FDA with a Form 483 last year. Story

> A report from Pew and others suggests ways to cut drug shortages in the U.S., including offering incentives and price flexibility to companies that expand capacity. Release

> Juno Therapeutics ($JUNO) will lease a manufacturing operation in Bothell, WA, that it would use to produce product for its clinical trials. Release

> George Karavetsos, who was executive assistant U.S. attorney for the Southern District of Florida, has taken over as head of the FDA Office of Criminal Investigations. Report

> UAE-based Gulf Pharma has bought Bangladesh drugmaker RAK Pharmaceuticals to expand in South Asia. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.